National Cancer Institute's (NCI) Investigational New Drug Application (IND) to begin a Phase II clinical trial
to investigate Lorus' lead antisense drug, GTI-2040, as a treatment for metastatic breast cancer in combination with capecitabine (Xeloda, Roche).
Our completed Phase I and Phase II clinical trial
results show that our lead compound, DAVANAT([R]), when co-administered with 5-Fluorouracil (5-FU), stabilized 43% of end-stage cancer patients with measurable disease from 2 to 13 months.
Nasdaq: SGEN) announced today that the company has initiated a phase II clinical trial
of SGN-40 for the treatment of patients with diffuse large B-cell lymphoma, the most common type of aggressive non-Hodgkin's lymphoma (NHL).
NASDAQ:DEPO) today announced that it has completed enrollment in a Phase II clinical trial
to evaluate its Gabapentin GR compound for the treatment of patients with painful diabetic peripheral neuropathy (DPN).
BOSTON & PERTH, Australia -- Global bio-nanotech company pSivida Limited (NASDAQ:PSDV) (ASX:PSD) (Xetra:PSI) today announced the initiation of a Phase II clinical trial
of Mifepristone (otherwise known as RU486) as an eye drop treatment for steroid associated elevated intraocular pressure (IOP).
Once this phase II clinical trial
is initiated, Can-Fite will have 3 applications for CF101 in its development pipeline.
Kendle will support CVBT in its Phase II clinical trial
ensuring that the protocol and study adhere to FDA regulatory requirements.
Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, received approval from the Israeli Ministry of Health (MoH) to conduct phase II clinical trial
with orally-administered CF101 in the treatment of dry eye syndrome (known as "keratoconjunctivitis sicca", or KCS).
The development program includes the previously announced proof of concept Phase II trial being conducted at University of California, San Diego and a company-sponsored open-label Phase II clinical trial
in refractory ovarian cancer patients in Europe that will be begin dosing shortly.
The Phase II clinical trial
will include an examination of not only the safety but of the efficacy of our drug candidate in a much larger population of patients with inoperable coronary heart disease.
CA4P is being evaluated in a Phase II clinical trial
in combination with the widely used chemotherapy regimen, carboplatin and paclitaxel, for the treatment of platinum resistant ovarian cancer.
Nasdaq:SGEN) today reported data from its ongoing phase II clinical trial
of SGN-30 in cutaneous anaplastic large cell lymphoma (ALCL) and other lymphoproliferative disorders at the Society of Investigative Dermatology annual meeting being held in Philadelphia May 3-6.